Description

(19S)-19-Cyano-14-[(20α)-19,20-Dihydro-17-Methoxy-17-Oxovobasan-3α-Yl]-13-Methoxyibogamine-18-Carboxylic Acid Methyl Ester is a complex, high-purity alkaloid derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical intermediate or reference standard for the synthesis and study of novel therapeutic agents targeting the central nervous system. It is primarily required by pharmaceutical R&D laboratories, contract research organizations (CROs), and academic institutions engaged in medicinal chemistry and neuropharmacology.

Application

• Pharmaceutical Intermediate: A key building block in the multi-step synthesis of complex alkaloid-based drug candidates.
• Reference Standard: Used for analytical method development, validation, and quality control in pharmaceutical manufacturing (HPLC, LC-MS).
• Medicinal Chemistry Research: A crucial substrate for structure-activity relationship (SAR) studies to explore new bioactive molecules.
• Neuroscience & Pharmacology Studies: Investigated for its potential interactions with specific neurotransmitter receptors and ion channels.
• Process Chemistry Development: Serves as a model compound for optimizing scalable synthetic routes under GMP-like conditions.
• Academic Research: Utilized in university laboratories for advanced studies in organic synthesis and natural product chemistry.

Basic Information

Product Name	(19S)-19-Cyano-14-[(20α)-19,20-Dihydro-17-Methoxy-17-Oxovobasan-3α-Yl]-13-Methoxyibogamine-18-Carboxylic Acid Methyl Ester
CAS No.	72542-42-8
Molecular Formula	C44H52N4O6
Molecular Weight	732.92 g/mol
Synonyms	19-Cyano-14-(19,20-dihydro-17-methoxy-17-oxovobasan-3α-yl)-13-methoxyibogamine-18-carboxylic acid methyl ester; Methyl 19-cyano-14-(19,20-dihydro-17-methoxy-17-oxovobasan-3α-yl)-13-methoxyibogamine-18-carboxylate; Ibogamine derivative 72542-42-8; 3α-Vobasan-17-methoxy-17-oxo-19,20-dihydro-14-yl ibogamine-18-methyl carboxylate-13-methoxy-19-nitrile; (19S)-19-Cyano-14-[(20α)-19,20-Dihydro-17-Methoxy-17-Oxovobasan-3α-Yl]-13-Methoxyibogamine-18-Carboxylic Acid Methyl Ester
EINECS	Contact for details

Quality Control

Our production of this high-value alkaloid derivative adheres to stringent quality management systems. Every batch is characterized and tested using advanced analytical techniques including HPLC, LC-MS, and NMR to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment. We support cGMP compliance for materials intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. This compound is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive); handle under an inert atmosphere if necessary for prolonged operations.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.